Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252010898 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Satendra Kumar und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Virology, Department of Veterinary Sciences, Ludwig Maximilians University Munich (LMU Munich), 85764 Oberschleißheim, Germany. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Vaccinia virus, Antibodies, Viral. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayerischer Forschungsverbund FOR-COVID.
Abstract (Originalsprache)
The emergence of hitherto unknown viral pathogens presents a great challenge for researchers to develop effective therapeutics and vaccines within a short time to avoid an uncontrolled global spread, as seen during the coronavirus disease 2019 (COVID-19) pandemic. Therefore, rapid and simple methods to identify immunogenic antigens as potential therapeutical targets are urgently needed for a better pandemic preparedness. To address this problem, we chose the well-characterized Modified Vaccinia virus Ankara (MVA)-T7pol expression system to establish a workflow to identify immunogens when a new pathogen emerges, generate candidate vaccines, and test their immunogenicity in an animal model. By using this system, we detected severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) nucleoprotein (N)-, and spike (S)-specific antibodies in COVID-19 patient sera, which is in line with the current literature and our observations from previous immunogenicity studies. Furthermore, we detected antibodies directed against the SARS-CoV-2-membrane (M) and -ORF3a proteins in COVID-19 patient sera and aimed to generate recombinant MVA candidate vaccines expressing either the M or ORF3a protein. When testing our candidate vaccines in a prime-boost immunization regimen in humanized HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice, we were able to demonstrate M- and ORF3a-specific cellular and humoral immune responses. Hence, the established workflow using the MVA-T7pol expression system represents a rapid and efficient tool to identify potential immunogenic antigens and provides a basis for future development of candidate vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Virology, Department of Veterinary Sciences, Ludwig Maximilians University Munich (LMU Munich), 85764 Oberschleißheim, Germany.
- German Center for Infection Research, Partner Site Munich, 85764 Oberschleißheim, Germany.
- Bundeswehr Institute of Microbiology, 80937 Munich, Germany.
- Chair of Bacteriology and Mycology, Department of Veterinary Sciences, Ludwig Maximilians University Munich (LMU Munich), 85764 Oberschleißheim, Germany.
- Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig Maximilians University Munich (LMU Munich), 80804 Munich, Germany.
- Medical Clinic III, University Hospital, Ludwig Maximilians University Munich (LMU Munich), 80336 Munich, Germany.
ORCID-Profile: Satendra Kumar, Liangliang Nan, Georgia Kalodimou, Katharina Müller, Philipp Girl, Asisa Volz, Gerd Sutter, Robert Fux
Förderung
- Bayerischer Forschungsverbund FOR-COVID
Zitieren
APA
Kumar, S., Nan, L., Kalodimou, G., Jany, S., Freudenstein, A., Brandmüller, C., Müller, K., Girl, P., Ehmann, R., Guggemos, W., Seilmaier, M., Wendtner, C. M., Volz, A., Sutter, G., Fux, R., & Tscherne, A. (2024). Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252010898
Vancouver
Kumar S, Nan L, Kalodimou G, Jany S, Freudenstein A, Brandmüller C, et al. Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252010898
BibTeX
@article{Kumar2024,
author = {Kumar, Satendra and Nan, Liangliang and Kalodimou, Georgia and Jany, Sylvia and Freudenstein, Astrid and Brandmüller, Christine and Müller, Katharina and Girl, Philipp and Ehmann, Rosina and Guggemos, Wolfgang and Seilmaier, Michael and Wendtner, Clemens-Martin and Volz, Asisa and Sutter, Gerd and Fux, Robert and Tscherne, Alina},
title = {Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252010898}
}
EUVIMED